Trolamine

Trolamine

SCHEMBL28007192

CCCCCCCCCCCCN(C)C(C)C(=O)O.OCCN(CCO)CCO

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ICMT O60725 1/20 0.38
ALB P02768 1/20 0.38
KDM5A P29375 3/20 0.38
PHF8 Q9UPP1 3/20 0.38
KDM4C Q9H3R0 2/20 0.38
ACE2 Q9BYF1 1/20 0.38
GPR84 Q9NQS5 3/20 0.37
FFAR1 O14842 1/20 0.37
MAPT P10636 1/20 0.36
LCK P06239 1/20 0.36
PPARD Q03181 1/20 0.36
ZDHHC20 Q5W0Z9 1/20 0.36
ZDHHC2 Q9UIJ5 1/20 0.36
MMP1 P03956 1/20 0.36
MMP3 P08254 1/20 0.36
DNM1 Q05193 4/20 0.35
GGPS1 O95749 3/20 0.35
EPHX2 P34913 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trolamine SCHEMBL7262076 1.00 ICMT (0.38) ICMTALBKDM5APHF8KDM4C
Trolamine SCHEMBL28075795 0.98 ICMT (0.36) ICMTALBKDM5APHF8KDM4C
SCHEMBL5495146 0.90 ACE2 (0.44) ACE2GPR84FFAR1MAPTLCK
SCHEMBL29176010 0.90 ACE2 (0.44) ACE2GPR84FFAR1MAPTLCK
SCHEMBL6811800 0.90 ACE2 (0.44) ACE2GPR84FFAR1MAPTLCK
SCHEMBL2175914 0.90 ACE2 (0.44) ACE2GPR84FFAR1MAPTLCK
SCHEMBL7500724 0.90 ACE2 (0.44) ACE2GPR84FFAR1MAPTLCK
SCHEMBL11442609 0.90 ACE2 (0.44) ACE2GPR84FFAR1MAPTLCK
SCHEMBL5495147 0.90 ACE2 (0.44) ACE2GPR84FFAR1MAPTLCK
SCHEMBL7497648 0.90 ACE2 (0.44) ACE2GPR84FFAR1MAPTLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104640534-A Two-phase composition comprising an alkyl polyglucoside and an ester having a melting point of less than 10 ℃ OREAL 2015-05-20 CN disclosed